A cross-disciplinary team created in response to rapid sector growth, increased FDA scrutiny and rising plaintiffs’ bar focus, our Women’s Health group advises drug and device manufacturers, healthcare providers, private equity firms and other clients throughout the product lifecycle on FDA matters, post-marketing safety and marketing issues, IP, corporate and M&A matters, coverage and reimbursement, healthcare provider issues and product liability risk.

Our team brings decades of experience with medical devices and pharmaceutical products, combining deep knowledge of the science, regulatory history, expert issues and litigation strategies that shape this space. Our experience spans matters involving breast implants, pelvic mesh, morcellators, diet drugs, antidepressants taken during pregnancy, osteoporosis medications, menopausal products, cosmetics, sunscreen, dermatology products and contraceptives. That breadth enables our lawyers to work seamlessly across regulatory, transactional and disputes disciplines to help clients bring products to market, respond to safety and marketing challenges, and defend against claims with strategies grounded in the science, legal arguments and industry realities that drive successful outcomes.